Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the schedule hereto:
Schedule
Product: Proleukin
Active Ingredient(s): Interleukin-2 (recombinant human) 18MIU/mL
Dosage Form: Powder for injection
NZ Sponsor: CSL (New Zealand) Limited
Manufacturer(s): Chiron bv, Amsterdam, The Netherlands

Product: Proleukin
Active Ingredient(s): Interleukin-2 (recombinant human) 9MIU
Dosage Form: Powder for injection
NZ Sponsor: CSL (New Zealand) Limited
Manufacturer(s): Chiron bv, Amsterdam, The Netherlands
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 21st day of January 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.